The successful transfusion of a cell-free blood product in the case of a 14-year-old Jehovah’s Witness may offer a solution for patients opposed to blood transfusions on religious or personal grounds.
“This was the first successful use of a human cell-free hemoglobin solution in a pediatric patient to manage life-threatening anemia due to an autoimmune disease,” says Dr. Brian Kavanagh, professor of medicine at U of T and staff physician in critical care medicine at The Hospital for Sick Children in Toronto.
The patient suffered from immune thrombocytopenia, a condition that attacks platelets in the blood. Platelets help blood clot; when platelet counts are very low, even minor injuries can become serious if a patient continues to bleed. Kavanagh and his colleagues treated the girl after she entered the hospital for a nosebleed that did not stop. Instead of a blood transfusion, they used a manufactured solution containing hemoglobin but no red blood cells. The solution had been used in adults but never for a child in this type of situation.
While more study needs to be done with pediatric patients, Kavanagh says this cell-free hemoglobin is a viable alternative for Jehovah’s Witnesses and others opposed to blood transfusions. Kavanagh and colleagues reported this case in a fall issue of the British Journal of Haematology.
Recent Posts
U of T’s 197th Birthday Quiz
Test your knowledge of all things U of T in honour of the university’s 197th anniversary on March 15!
Work Has Changed. So Have the Qualities of Good Leadership
Rapid shifts in everything from technology to employee expectations are pressuring leaders to constantly adapt